ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $909 | -99.8% | 145,953 | +74.7% | 0.00% | 0.0% |
| Q3 2022 | $559,000 | +171.4% | 83,568 | +158.0% | 0.00% | – |
| Q2 2022 | $206,000 | -21.1% | 32,392 | -42.6% | 0.00% | – |
| Q1 2022 | $261,000 | +44.2% | 56,427 | +55.5% | 0.00% | – |
| Q4 2021 | $181,000 | -91.1% | 36,291 | -78.6% | 0.00% | -100.0% |
| Q3 2021 | $2,041,000 | +257.4% | 169,400 | +527.4% | 0.00% | +100.0% |
| Q2 2021 | $571,000 | -34.7% | 27,000 | +123.0% | 0.00% | 0.0% |
| Q1 2018 | $875,000 | +641.5% | 12,106 | +734.9% | 0.00% | – |
| Q2 2015 | $118,000 | -95.1% | 1,450 | -94.5% | 0.00% | -100.0% |
| Q1 2015 | $2,430,000 | +30275.0% | 26,245 | +13022.5% | 0.01% | – |
| Q4 2014 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |